Product Center
Received national level praise!
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-03-01
- Views:
(Summary description)Recently, recommended by the provincial adverse drug reaction monitoring institutions and comprehensively evaluated by the National Adverse Drug Reaction Monitoring Center, Ab&B Bio-Tech CO., LTD. JS has outstanding performance in fulfilling its main responsibilities in the monitoring of adverse drug reactions in 2023 and has been praised by the National Adverse Reaction Monitoring Center.
Received national level praise!
(Summary description)Recently, recommended by the provincial adverse drug reaction monitoring institutions and comprehensively evaluated by the National Adverse Drug Reaction Monitoring Center, Ab&B Bio-Tech CO., LTD. JS has outstanding performance in fulfilling its main responsibilities in the monitoring of adverse drug reactions in 2023 and has been praised by the National Adverse Reaction Monitoring Center.
- Categories:Company news
- Author:
- Origin:
- Time of issue:2024-03-01 16:18
- Views:
Recently, recommended by the provincial adverse drug reaction monitoring institutions and comprehensively evaluated by the National Adverse Drug Reaction Monitoring Center, Ab&B Bio-Tech CO., LTD. JS has outstanding performance in fulfilling its main responsibilities in the monitoring of adverse drug reactions in 2023 and has been praised by the National Adverse Reaction Monitoring Center.
The achievement of the results fully reflects the affirmation of the preliminary work of Ab&B Bio-Tech CO.,LTD.JS by adverse drug reaction monitoring institutions at all levels, and Ab&B Bio-Tech CO.,LTD.JS will cherish the honor, continue to implement the "four strictest" requirements and the spirit of General Secretary Xi Jinping's series of important instructions on drug safety work, and perform their duties with a stronger sense of responsibility and mission, improve their pharmacovigilance ability, and contribute to the protection of public health!
Relevant information
-
Ab&B Bio and Yither Bio have both obtained qualification certification!Recently, Ab&B Bio-Tech Co.,Ltd（Ab&B Bio） and its subsidiary Yither biotech (Shanghai) Co., Ltd (Yither Bio) have been recognized as Jiangsu Province's specialized and innovative small and medium-sized enterprises and national high-tech enterprises, respectively. - The kickoff meeting for clinical research on the immunogenicity and safety of quadrivalent influenza virus subunit vaccine for children with nephrotic syndrome was successfully held 12-25
- Influenza virus subunit vaccine (adjuvant) IND application approved 10-30
- The application for the marketing of trivalent influenza virus subunit vaccine has been accepted! 10-08
- Breaking through bottleneck technology, significant progress has been made in the research and development of new adjuvants 08-26
Have a project？Get a touch!
Caring for life, protecting health, and making global technological innovation vaccines are the mission of Ab&B Bio
Contact
E-mail:info@abbbio.com.cn
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
